网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
西酞普兰对睡眠障碍大鼠Nrf2/ARE/HO-1通路及学习记忆能力的影响
作者:程闯1  李娟2  王红雷1  刘国1 
单位:1. 荆州市精神卫生中心 精神科, 湖北 荆州 434000;
2. 荆州市第二人民医院普外科, 湖北 荆州 434000
关键词:西酞普兰 睡眠障碍 核因子E2相关因子2/抗氧化反应元件/血红素加氧酶-1通路 学习记忆能力 
分类号:R364
出版年·卷·期(页码):2022·41·第十一期(1361-1366)
摘要:

目的:探讨西酞普兰对睡眠障碍大鼠核因子E2相关因子2(Nrf2)/抗氧化反应元件(ARE)/血红素加氧酶-1(HO-1)通路及学习记忆能力的影响。方法:将SD大鼠分为对照组(灌胃生理盐水)、模型组(建模+灌胃生理盐水)、西酞普兰低剂量组(建模+灌胃1.05 mg·kg-1西酞普兰)、西酞普兰中剂量组(建模+灌胃2.1 mg·kg-1西酞普兰)和西酞普兰高剂量组(建模+灌胃4.2 mg·kg-1西酞普兰)。Morris水迷宫实验检测大鼠学习记忆能力,酶联免疫吸附试验测定谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)活性及丙二醛(MDA)含量,蛋白印迹法检测Nrf2、HO-1蛋白表达。结果:与对照组相比,模型组大鼠的目标象限停留时间百分比、穿越平台次数显著减少(P<0.05),逃避潜伏期显著延长(P<0.05),海马组织中GSH-Px、SOD活性及Nrf2、HO-1蛋白水平显著降低(P<0.05),MDA含量显著升高(P<0.05);随着西酞普兰的使用及剂量的升高,大鼠的逃避潜伏期缩短(P<0.05),目标象限停留时间百分比、穿越平台次数显著增多(P<0.05),海马组织中GSH-Px、SOD活性及Nrf2、HO-1蛋白水平显著升高(P<0.05),MDA含量显著降低(P<0.05)。结论:西酞普兰能提高睡眠障碍大鼠学习记忆能力,其机制可能与激活Nrf2/ARE/HO-1通路有关。

Objective: To investigate the effects of citalopram on nuclear factor erythroid 2 related factor 2(Nrf2)/ antioxidant response element(ARE)/ heme oxygenase-1(HO-1) pathway and learning and memory ability in rats with sleep disorder. Methods: SD rats were divided into control group(intragastric administration of normal saline), model group(modeling+intragastric administration of normal saline), low-dose citalopram group(modeling+intragastric administration of 1.05 mg·kg-1 citalopram), medium-dose citalopram group(modeling+intragastric administration of 2.1 mg·kg-1 citalopram) and high-dose citalopram group(modeling+intragastric administration of 4.2 mg·kg-1 citalopram). The learning and memory ability of rats were detected by morris water maze test, the activity of glutathion peroxidase(GSH-Px), superoxide dismutase(SOD) and the content of malondialdehyde(MDA) in hippocampus were detected by enzyme linked immunosorbent assay, the expression of Nrf2 and HO-1 protein in hippocampus were detected by Western blot. Results: Compared with the control group, the percentage of target quadrant residence time and the frequency of crossing platform in the model group were significantly decreased(P<0.05), the escape latency time was significantly increased(P<0.05), the activities of GSH-Px and SOD, the levels of Nrf2 and HO-1 protein in hippocampus were decreased(P<0.05), the content of MDA was significantly increased(P<0.05). With the increase of citalopram dose, the escape latency time of rats was decreased(P<0.05), the percentage of target quadrant residence time and the times of crossing platform were significantly increased(P<0.05), the activities of GSH-Px and SOD, the protein levels of Nrf2 and HO-1 in hippocampus were significantly increased(P<0.05), the content of MDA was significantly decreased(P<0.05). Conclusion: Citalopram can improve the learning and memory ability of rats with sleep disorder, and its mechanism may be related to the activation of Nrf2/ARE/HO-1 pathway.

参考文献:

[1] 刘俊昌,刘文超,辛春光,等.摩腹疗法对焦虑型睡眠障碍大鼠血清NE、EPI含量的影响[J].中华中医药杂志,2018,33(7):3124-3126.
[2] NAZEM S,FORSTER J E,BRENNER L A,et al.Actigraphic and sleep diary measures in veterans with traumatic brain injury:discrepancy in selected sleep parameters[J].J Head Trauma Rehabil,2016,31(2):136-146.
[3] YIN Z,CHANG M,WEI S,et al.Decreased functional connectivity in insular subregions in depressive episodes of bipolar disorder and major depressive disorder[J].Front Neurosci,2018,12(1):842-851.
[4] LIU Z,WANG F,TANG M,et al.Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor[J].Int J Mol Med,2019,43(1):435-442.
[5] REEVE S,SHEAVES B,FREEMAN D.Sleep disorders in early psychosis:incidence,severity,and association with clinical symptoms[J].Schizophr Bull,2019,45(2):287-295.
[6] SALEHPOUR F,FARAJDOKHT F,ERFANI M,et al.Transcranial near-infrared photobiomodulation attenuates memory impairment and hippocampal oxidative stress in sleep-deprived mice[J].Brain Res,2018,1682(1):36-43.
[7] MORRONI F,SITA G,GRAZIOSI A,et al.Neuroprotective effect of caffeic acid phenethyl ester in a mouse model of alzheimer's disease involves Nrf2/HO-1 pathway[J].Aging Dis,2018,9(4):605-622.
[8] 王化强,林炜,刘军,等.米氮平联合西酞普兰治疗抑郁伴睡眠障碍患者的效果观察[J].国际精神病学杂志,2019,46(2):286-288.
[9] 俞裕天,荣培晶,唐纯志.针药并用对抑郁症睡眠障碍大鼠下丘脑、杏仁核、中缝背核5-HT与5-HIAA含量及其比值的影响[J].上海针灸杂志,2017,36(3):337-342.
[10] 邓巍,杜晓娜,施学丽,等.对药酸枣仁-合欢花对抑郁症睡眠障碍模型大鼠行为学及海马5-HT、5-HIAA含量的影响[J].广西中医药,2019,42(5):63-66.
[11] 郝婷婷,郭浩,刘建勋,等.2种分析方法对睡眠剥夺大鼠血瘀证评价的初步研究[J].中国中药杂志,2018,43(9):1880-1885.
[12] DANESHZAD E,KESHAVARZ S A,QORBANI M,et al.Dietary total antioxidant capacity and its association with sleep,stress,anxiety,and depression score:a cross-sectional study among diabetic women[J].Clin Nutr ESPEN,2020,37(1):187-194.
[13] TIAN H,DING N,GUO M,et al.Analysis of learning and memory ability in an alzheimer's disease mouse model using the morris water maze[J].J Vis Exp,2019,1(152):1-6.
[14] WANG S,SU G,ZHANG Q,et al.Walnut( Juglans regia) peptides reverse sleep deprivation-induced memory impairment in rat via alleviating oxidative stress[J].J Agric Food Chem,2018,66(40):10617-10627.
[15] ZHAO X,YANG D,XU W,et al.Effect of irbesartan on oxidative stress and serum inflammatory factors in renal tissues of type 2 diabetic rats[J].J Coll Physicians Surg Pak,2019,29(5):422-425.
[16] 薛李,田宏,王丽霞.艾司西酞普兰联合不同剂量米氮平治疗伴焦虑症状抑郁症的效果及安全性分析[J].解放军医药杂志,2019,31(3):72-75.
[17] MI W F,TABARAK S,WANG L,et al.Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder:evidence from polysomnographic and resting-state functional connectivity analyses[J].Sleep,2020,43(11):zsaa092.
[18] 郭洪林,张月良,杨晓琴,等.西酞普兰联合米氮平对重度抑郁症伴睡眠障碍患者的睡眠质量、生活质量及氧化应激水平的影响[J].国际精神病学杂志,2018,45(5):858-874.
[19] 公卫刚,任庆国.西酞普兰对成年孤养大鼠认知功能及皮层tau蛋白磷酸化的影响[J].中华行为医学与脑科学杂志,2016,25(3):193-197.
[20] ALHAITHLOUL H A S,ALOTAIBI M F,BIN-JUMAH M,et al.Olea europaea leaf extract up-regulates Nrf2/ARE/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress,inflammation and apoptosis in rat kidney[J].Biomed Pharmacother,2019,111(1):676-685.
[21] 张倩,冯晴霞,周正乙,等.刺五加苷B对疲劳小鼠学习记忆能力的改善作用及其激活Keap1/Nrf2/ARE信号通路的机制[J].吉林大学学报(医学版),2020,46(4):771-778.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752197 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541